Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response

28 kDa GST proteins from schistosoma for the use thereof in the treatment of inflammatory autoimmune diseases generating a Th1 and/or Th17 response

US Patent 9593313 · Granted Mar 14, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method of treating Crohn's disease by administering a triple combination therapy2025
Triple combination therapy for treating Crohn's disease2021
Synthetic oligomannosides, preparation and uses thereof2006
RECOMBINANT PROTEINS OF FILAMENTOUS HAEMAGGLUTININ OF BORDETELLA, PARTICULARLY B2005
Bordetella strain expressing the FHA hybrid, liposomes and vaccines2003